1-6 of 6
Muneyuki Masuda
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract PO-063: Environment-induced YAP1 transcriptional reprogramming drives head and neck cancer

Muneyuki Masuda, Hirofumi Omori, Kuniaki Sato, Josef Penninger, Silvio Gutkind
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (18_Supplement): PO-063.
https://doi.org/10.1158/1557-3265.AACRAHNS23-PO-063
Published: 15 September 2023
View articletitled, Abstract PO-063: Environment-induced YAP1 transcriptional reprogramming drives head and neck cancer
Journal Articles

Abstract B16: Transcriptional addiction to YAP1—the major driving force of oral cancer carcinogenesis and evolution

Muneyuki Masuda, Hirofumi Omori, Kuniaki Sato, Kenichi Taguchi, Masashige Bando, Satoshi Toh, Katsuhiko Shirahige, Koshi Mimori, Akira Suzuki
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (12_Supplement_2): B16.
https://doi.org/10.1158/1557-3265.AACRAHNS19-B16
Published: 15 June 2020
View articletitled, Abstract B16: Transcriptional addiction to YAP1—the major driving force of oral cancer carcinogenesis and evolution
Journal Articles

Abstract 15: Utility of chemoradioselection for the optimization of treatment intensity in advanced hypopharyngeal and laryngeal carcinoma

Muneyuki Masuda, Satoshi Toh, Hidefumi Rikimaru, Naonobu Kunitake, Yuichiro Higaki
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (23_Supplement): 15.
https://doi.org/10.1158/1557-3265.AACRAHNS17-15
Published: 30 November 2017
View articletitled, Abstract 15: Utility of chemoradioselection for the optimization of treatment intensity in advanced hypopharyngeal and laryngeal carcinoma
Journal Articles

Sulindac Sulfide and Exisulind Inhibit Expression of the Estrogen and Progesterone Receptors in Human Breast Cancer Cells

Jin T.E. Lim, Andrew K. Joe, Masumi Suzui, Masahito Shimizu, Muneyuki Masuda, I. Bernard Weinstein
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (11): 3478–3484.
https://doi.org/10.1158/1078-0432.CCR-05-2051
Published: 01 June 2006
View articletitled, Sulindac Sulfide and Exisulind Inhibit Expression of the Estrogen and Progesterone Receptors in Human Breast Cancer Cells
Open the PDF for Sulindac Sulfide and Exisulind Inhibit Expression of the Estrogen and Progesterone Receptors in Human Breast Cancer Cells in another window
Journal Articles

Epigallocatechin-3-gallate Inhibits Activation of HER-2/neu and Downstream Signaling Pathways in Human Head and Neck and Breast Carcinoma Cells

Muneyuki Masuda, Masumi Suzui, Jin T. E. Lim, I. Bernard Weinstein
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (9): 3486–3491.
Published: 05 September 2003
View articletitled, Epigallocatechin-3-gallate Inhibits Activation of HER-2/neu and Downstream Signaling Pathways in Human Head and Neck and Breast Carcinoma Cells
Open the PDF for Epigallocatechin-3-gallate Inhibits Activation of HER-2/neu and Downstream Signaling Pathways in Human Head and Neck and Breast Carcinoma Cells in another window
Journal Articles

Effects of Epigallocatechin-3-gallate on Growth, Epidermal Growth Factor Receptor Signaling Pathways, Gene Expression, and Chemosensitivity in Human Head and Neck Squamous Cell Carcinoma Cell Lines

Muneyuki Masuda, Masumi Suzui, I. Bernard Weinstein
Journal: Clinical Cancer Research
Clin Cancer Res (2001) 7 (12): 4220–4229.
Published: 01 December 2001
View articletitled, Effects of Epigallocatechin-3-gallate on Growth, Epidermal Growth Factor Receptor Signaling Pathways, Gene Expression, and Chemosensitivity in Human Head and Neck Squamous Cell Carcinoma Cell Lines
Open the PDF for Effects of Epigallocatechin-3-gallate on Growth, Epidermal Growth Factor Receptor Signaling Pathways, Gene Expression, and Chemosensitivity in Human Head and Neck Squamous Cell Carcinoma Cell Lines in another window